About Nexalin Technology Inc
- Industry: Health Care
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://nexalin.com
Frequently Asked Questions
What is the 52-week range for NXL?
The 52-week high is $60 and the 52-week low is $4.
What is the P/E ratio for NXL?
The P/E ratio data is currently unavailable.
What is the dividend yield for NXL?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -278.25%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -4139.28%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 9.66.
Analyst Recommendation Trends
Wall Street analyst consensus for NXL over the last few months:
Latest NXL News
Friday's session: top gainers and losers
Intrigued by the market activity one hour before the close of the markets on Friday? Uncover the key winners and losers of today's session in our insightful analysis.
These stocks are moving in today's session
Curious to know what's happening on the US markets in the middle of the day on Friday? Join us as we explore the top gainers and losers in today's session.
Friday's session: gap up and gap down stocks
The market is filled with gapping stocks in Friday's session. Let's discover which stocks are showing gap-ups and gap-downs.
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Stablecoin Development (AMEX:SDEV) shares moved upwards by 66.9% to $6.11 during Friday's regular session. The company's market cap stands at $99.2 million. QTREX Quantum (NASDAQ:QTEX) stock rose
Friday's pre-market session: top gainers and losers
Before the US market kicks off on Friday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Dow Jumps Over 300 Points; US Economy Adds 29,000 Jobs In September
U.S. stocks climbed Friday, led by Nasdaq; September jobs missed forecasts, unemployment rose, oil fell, and speculative shares surged.
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers NewGenIvf Group (NASDAQ:NIVF) stock moved upwards by 56.7% to $0.16 during Friday's pre-market session. Stablecoin Development (AMEX:SDEV) stock rose 30.86% to $4.79. The company's market cap stands at
Why Synaptics Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
Synaptics surged 14.5% after amending its $123/share cash buyout by onsemi; AMOD led gainers, while WCT fell 20.3% premarket.
Which stocks are experiencing notable movement on Thursday?
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Top Midday Gainers
Nexalin Technology (NXL) signed an agreement to appoint Inovanexa Medical Technologies as its exclus
Thursday's session: gap up and gap down stocks
The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Nexalin Technology Signs South America Distribution Agreement for Nexalin Sync Commercialization
The 10-year exclusive agreement covers seven countries and includes an initial binding device order, a Brazilian clinical pilot and a framework for locally manufactured devices and recurring electrode royalties. Key Investor TakeawaysNexalin Technology (NASDAQ:NXL) signed a definitive exclusive South America distribution agreement with Inovanexa Medical Technologies covering Brazil, Argentina, Chile, Uruguay, Paraguay, Ecuador and Venezuela.
Nasdaq Gains 100 Points; ISM manufacturing PMI Slips In September
U.S. stocks edged higher Thursday; Nasdaq rose 0.37%, energy led gains, Accenture surged 18%, and Corteva plunged 84%.
Why Is Nexalin Technology Stock Gaining Thursday?
Nexalin Technology (NXL) stock surged 80% on massive volume following a 10-year South American distribution and manufacturing deal.
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Nexalin Technology (NASDAQ:NXL) shares increased by 77.8% to $7.61 during Thursday's regular session. The company's market cap stands at $3.5 million. Stablecoin Development (AMEX:SDEV) stock rose
Nexalin Technology Signs Definitive Exclusive Distribution and Local Manufacturing Agreement for Brazil and South America, Marking a Major Step in its Transition Toward Commercial Revenue Generation
Agreement establishes an initial 100-device commercialization program for the ANVISA-approved Nexalin Sync™ across seven countries and more than 300 million people, with a structured pricing framework and a mechanism for larger strategic transactions with government and private-sector customers Agreement establishes a 10-year commercial framework covering Brazil, Argentina, Chile, Uruguay, Paraguay, Ecuador and Venezuela, anchored by an initial 100-device commercialization program and minimum re
Dow Falls Over 200 Points; Micron Earnings Top Views
U.S. stocks slipped Thursday as the Dow fell over 200 points; energy and oil rose, Micron beat estimates, and European markets declined.
Nexalin Signs 10-Year Exclusive Distribution Deal With Inovanexa Medical Technologies Covering Seven Latin American Markets
Agreement establishes an initial 100-device commercialization program for the ANVISA-approved Nexalin Sync™ across seven countries and more than 300 million people, with a structured pricing framework and a mechanism
Nexalin Technology Taps Neuromodulation Commercial Executive Robert DiTota to Advise on its Global Commercialization Strategy
Appointment as Senior Strategic Advisor marks the Company’s expansion from clinical development toward commercialization of its DIFS™ platform in the United States, Europe and South America DiTota spent over two decades in neuromodulation at Abbott and Medtronic, two of the largest companies in the field, including responsibility for Abbott’s North America commercial neuromodulation business, a division representing approximately $700 million in business Nexalin’s Gen-2 SYNC device is already ap
Anixa Biosciences and Nexalin Technology Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
ORLANDO, FL / ACCESS Newswire / September 11, 2026 / RedChip Companies will air interviews with Anixa Biosciences Inc. (NASDAQ:ANIX) and Nexalin Technology Inc.
Nexalin Technology Announces New Secondary Analysis of Previously Published Clinical Trial Data Reveals Previously Unreported Improvements in Memory, Comprehension and Language Function in Alzheimer’s Patients; ADAS-Cog Subscale Analysis to Guide Design of Planned U.S. Alzheimer’s Pilot Study
Further analysis of ADAS-Cog data from the Company’s randomized, sham-controlled clinical trial — previously published in the Journal of Alzheimer’s Disease and in Radiology — identifies specific improvements in cognitive domains associated with memory in Alzheimer’s patients One half of evaluable active-arm participants achieved a clinically meaningful improvement of four or more points on the ADAS-Cog, with domain-level gains in comprehension, memory and language function still evident three m
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2025-12-19 | White Mark | +1,000,000 | - | - |
| 2025-12-19 | Van Fleet Justin | +100,000 | - | - |
| 2025-12-19 | Owens David | +1,000,000 | - | - |
| 2025-12-19 | Shelton Carolyn Hamby | +100,000 | - | - |
| 2025-12-19 | Hu Ben | +100,000 | - | - |
| 2025-12-19 | Kazden Alan | +100,000 | - | - |